X0708 D/A LIVE 0001809726 Claris Biotherapeutics, Inc. 475 MAGELLAN AVE HALF MOON BAY CA CALIFORNIA 94019 201-344-7638 DELAWARE None None Corporation true Stephen Brady c/o Claris Biotherapeutics, Inc. 475 Magellan Ave Half Moon Bay CA CALIFORNIA 94019 Executive Officer Director Reza Dana c/o Claris Biotherapeutics, Inc. 475 Magellan Ave Half Moon Bay CA CALIFORNIA 94019 Director Kenneth Harrison c/o Claris Biotherapeutics, Inc. 475 Magellan Ave Half Moon Bay CA CALIFORNIA 94019 Director Marc de Garidel c/o Claris Biotherapeutics, Inc. 475 Magellan Ave Half Moon Bay CA CALIFORNIA 94019 Director Meredith Fisher c/o Claris Biotherapeutics, Inc. 475 Magellan Ave Half Moon Bay CA CALIFORNIA 94019 Director Henry Rath c/o Claris Biotherapeutics, Inc. 475 Magellan Ave Half Moon Bay CA CALIFORNIA 94019 Executive Officer Susan Orr c/o Claris Biotherapeutics, Inc. 475 Magellan Ave Half Moon Bay CA CALIFORNIA 94019 Executive Officer Michael Dybbs c/o Claris Biotherapeutics, Inc. 475 Magellan Ave Half Moon Bay CA CALIFORNIA 94019 Director Matt Hobson c/o Claris Biotherapeutics, Inc. 475 Magellan Ave Half Moon Bay CA CALIFORNIA 94019 Director Maha Radhakrishnan c/o Claris Biotherapeutics, Inc. 475 Magellan Ave Half Moon Bay CA CALIFORNIA 94019 Director Clarke Atwell c/o Claris Biotherapeutics, Inc. 475 Magellan Ave Half Moon Bay CA CALIFORNIA 94019 Executive Officer Brian Baum c/o Claris Biotherapeutics, Inc. 475 Magellan Ave Half Moon Bay CA CALIFORNIA 94019 Executive Officer Biotechnology Decline to Disclose 06b true 0001809726-26-000003 2025-11-25 false true true false 0 121477910 55737646 65740264 false 14 0 0 3100000 true This estimate is based on the expected time period for R&D/related activities to be funded by the proceeds set forth in Item 13(b) above and the aggregate regular/continuing compensation for these individuals? services during that period false Claris Biotherapeutics, Inc. /s/ Henry Rath Henry Rath Chief Business Officer 2026-08-12